Cargando…

Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery

[Image: see text] Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based n...

Descripción completa

Detalles Bibliográficos
Autores principales: Priya, Sakshi, Desai, Vaibhavi Meghraj, Singhvi, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835629/
https://www.ncbi.nlm.nih.gov/pubmed/36643539
http://dx.doi.org/10.1021/acsomega.2c05976
_version_ 1784868706615033856
author Priya, Sakshi
Desai, Vaibhavi Meghraj
Singhvi, Gautam
author_facet Priya, Sakshi
Desai, Vaibhavi Meghraj
Singhvi, Gautam
author_sort Priya, Sakshi
collection PubMed
description [Image: see text] Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based nanocarrier systems have gained tremendous attention over the years because of their noteworthy properties like high drug-loading capacity, lower toxicity, better bioavailability and biocompatibility, stability in the gastrointestinal tract, controlled release, simpler scale-up, and validation process. Nanocarriers still have some disadvantages like poor drug penetration, limited drug encapsulation, and poor targeting. These disadvantages can be overcome by their surface modification. Surface-modified nanocarriers result in controlled release, enhanced penetration efficiency, and targeted medication delivery. In this review, the authors summarize the numerous lipid-based nanocarriers and their functionalization through various surface modifiers such as polymers, ligands, surfactants, and fatty acids. Recent examples of newly developing surface-modified lipid-based nanocarrier systems from the available literature, along with their applications, have been compiled in this work.
format Online
Article
Text
id pubmed-9835629
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-98356292023-01-13 Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery Priya, Sakshi Desai, Vaibhavi Meghraj Singhvi, Gautam ACS Omega [Image: see text] Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based nanocarrier systems have gained tremendous attention over the years because of their noteworthy properties like high drug-loading capacity, lower toxicity, better bioavailability and biocompatibility, stability in the gastrointestinal tract, controlled release, simpler scale-up, and validation process. Nanocarriers still have some disadvantages like poor drug penetration, limited drug encapsulation, and poor targeting. These disadvantages can be overcome by their surface modification. Surface-modified nanocarriers result in controlled release, enhanced penetration efficiency, and targeted medication delivery. In this review, the authors summarize the numerous lipid-based nanocarriers and their functionalization through various surface modifiers such as polymers, ligands, surfactants, and fatty acids. Recent examples of newly developing surface-modified lipid-based nanocarrier systems from the available literature, along with their applications, have been compiled in this work. American Chemical Society 2022-12-20 /pmc/articles/PMC9835629/ /pubmed/36643539 http://dx.doi.org/10.1021/acsomega.2c05976 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Priya, Sakshi
Desai, Vaibhavi Meghraj
Singhvi, Gautam
Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
title Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
title_full Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
title_fullStr Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
title_full_unstemmed Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
title_short Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
title_sort surface modification of lipid-based nanocarriers: a potential approach to enhance targeted drug delivery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835629/
https://www.ncbi.nlm.nih.gov/pubmed/36643539
http://dx.doi.org/10.1021/acsomega.2c05976
work_keys_str_mv AT priyasakshi surfacemodificationoflipidbasednanocarriersapotentialapproachtoenhancetargeteddrugdelivery
AT desaivaibhavimeghraj surfacemodificationoflipidbasednanocarriersapotentialapproachtoenhancetargeteddrugdelivery
AT singhvigautam surfacemodificationoflipidbasednanocarriersapotentialapproachtoenhancetargeteddrugdelivery